Annual Short Term Debt
$735.00 K
+$78.00 K+11.87%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual short term debt is $735.00 thousand, with the most recent change of +$78.00 thousand (+11.87%) on December 31, 2023.
- During the last 3 years, ARQT annual short term debt has risen by +$735.00 thousand (+100.00%).
- ARQT annual short term debt is now at all-time high.
Performance
ARQT Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$100.31 M
+$99.53 M+12810.04%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly short term debt is $100.31 million, with the most recent change of +$99.53 million (+12810.04%) on September 30, 2024.
- Over the past year, ARQT quarterly short term debt has increased by +$99.60 million (+13929.51%).
- ARQT quarterly short term debt is now at all-time high.
Performance
ARQT Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ARQT Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.9% | +10000.0% |
| 3 y3 years | +100.0% | +10000.0% |
| 5 y5 years | +100.0% | +10000.0% |
ARQT Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.8% | at high | >+9999.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Arcutis Biotherapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $100.31 M(>+9900.0%) |
| Jun 2024 | - | $777.00 K(+2.8%) |
| Mar 2024 | - | $756.00 K(+2.9%) |
| Dec 2023 | $735.00 K(+11.9%) | $735.00 K(+2.8%) |
| Sep 2023 | - | $715.00 K(+2.9%) |
| Jun 2023 | - | $695.00 K(+2.8%) |
| Mar 2023 | - | $676.00 K(+2.9%) |
| Dec 2022 | $657.00 K | $657.00 K(+2.8%) |
| Sep 2022 | - | $639.00 K(+9.8%) |
| Jun 2022 | - | $582.00 K(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $507.00 K(+17.1%) |
| Dec 2021 | $433.00 K(>+9900.0%) | $433.00 K(+41.5%) |
| Sep 2021 | - | $306.00 K(+188.7%) |
| Jun 2021 | - | $106.00 K(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2020 | - | $32.00 K(-60.0%) |
| Jun 2020 | - | $80.00 K(-56.0%) |
| Mar 2020 | - | $182.00 K(+2.2%) |
| Dec 2019 | $178.00 K(>+9900.0%) | $178.00 K(+2.9%) |
| Sep 2019 | - | $173.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Arcutis Biotherapeutics annual short term debt?
- What is the all time high annual short term debt for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual short term debt year-on-year change?
- What is Arcutis Biotherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly short term debt year-on-year change?
What is Arcutis Biotherapeutics annual short term debt?
The current annual short term debt of ARQT is $735.00 K
What is the all time high annual short term debt for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual short term debt is $735.00 K
What is Arcutis Biotherapeutics annual short term debt year-on-year change?
Over the past year, ARQT annual short term debt has changed by +$78.00 K (+11.87%)
What is Arcutis Biotherapeutics quarterly short term debt?
The current quarterly short term debt of ARQT is $100.31 M
What is the all time high quarterly short term debt for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly short term debt is $100.31 M
What is Arcutis Biotherapeutics quarterly short term debt year-on-year change?
Over the past year, ARQT quarterly short term debt has changed by +$99.60 M (+13929.51%)